|By Marketwired .||
|August 5, 2014 07:03 AM EDT||
BEDMINSTER, NJ and DUBLIN, IRELAND--(Marketwired - August 05, 2014) - Amarin Corporation plc (NASDAQ: AMRN), a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health, today announced that it will host a conference call with members of Amarin senior management to discuss the company's second quarter 2014 financial results and provide an operational update on Thursday, August 7, at 4:30 p.m. ET. The conference call will follow the anticipated release of the company's second quarter 2014 financial results earlier that day.
The conference call can be heard live via the investor relations section of the company's website at www.amarincorp.com, or via telephone by dialing 877-407-8033 within the United States or 201-689-8033 from outside the United States. A replay of the call will be made available for a period of two weeks following the conference call. To hear a replay of the call, dial 877-660-6853 (inside the United States) or 201-612-7415 (outside the United States). A replay of the call will also be available through the company's website shortly after the call. For both dial-in numbers please use conference ID 13586651.
Amarin Corporation plc is a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health. Amarin's product development program leverages its extensive experience in lipid science and the potential therapeutic benefits of polyunsaturated fatty acids. Vascepa® (icosapent ethyl), Amarin's first FDA approved product, is an ultra-pure, EPA-only, omega-3 fatty acid product available by prescription. For more information about Vascepa visit www.vascepa.com. For more information about Amarin visit www.amarincorp.com.
Availability of other information about Amarin
Investors and others should note that we communicate with our investors and the public using our company website (www.amarincorp.com), our investor relations website (http://www.amarincorp.com/investor-splash.html), including but not limited to investor presentations and investor FAQs, Securities and Exchange Commission filings, press releases, public conference calls and webcasts. The information that we post on these channels and websites could be deemed to be material information. As a result, we encourage investors, the media, and others interested in Amarin to review the information that we post on these channels, including our investor relations website, on a regular basis. This list of channels may be updated from time to time on our investor relations website and may include social media channels. The contents of our website or these channels, or any other website that may be accessed from our website or these channels, shall not be deemed incorporated by reference in any filing under the Securities Act of 1933.
Aug. 30, 2015 01:00 AM EDT Reads: 378
Aug. 30, 2015 01:00 AM EDT Reads: 422
Aug. 30, 2015 01:00 AM EDT Reads: 465
Aug. 30, 2015 01:00 AM EDT Reads: 198
With the proliferation of connected devices underpinning new Internet of Things systems, Brandon Schulz, Director of Luxoft IoT – Retail, will be looking at the transformation of the retail customer experience in brick and mortar stores in his session at @ThingsExpo. Questions he will address include: Will beacons drop to the wayside like QR codes, or be a proximity-based profit driver? How will the customer experience change in stores of all types when everything can be instrumented and a...
Aug. 29, 2015 11:45 PM EDT Reads: 419
Aug. 29, 2015 10:00 PM EDT Reads: 317
Aug. 29, 2015 07:30 PM EDT Reads: 374
Aug. 29, 2015 07:15 PM EDT Reads: 377
Aug. 29, 2015 07:15 PM EDT Reads: 364
Aug. 29, 2015 04:00 PM EDT Reads: 319
Aug. 29, 2015 03:45 PM EDT Reads: 102
Aug. 29, 2015 01:00 PM EDT Reads: 145
Aug. 29, 2015 12:00 PM EDT Reads: 142
Aug. 29, 2015 11:45 AM EDT Reads: 151
Aug. 29, 2015 11:30 AM EDT Reads: 200